As women have begun having babies later in life, the number of patients going through in vitro fertilization treatment has increased significantly.
The medical treatment can be life-changing, but it also comes at a price, as some couples go deeply into debt to pay for medical care that health insurance does not always cover. Some research has questioned the effectiveness of newer aspects of fertility treatment, like genetic screenings, and some patients have filed lawsuits claiming that faulty chemicals destroyed their embryos. Private equity companies, seeing the industry’s rapid growth, have been buying up some of the country’s largest fertility clinics.
The New York Times is looking to hear from readers who can share their recent experiences with in vitro fertilization treatment. Hearing from patients helps us better understand where we should focus our reporting.
We will not publish any part of your response to this questionnaire without talking with you first. We will not share your contact information outside the Times newsroom, and we will use it only to reach out to you. If you’d feel more comfortable sharing your story with us anonymously, please visit our tips page.
Sarah Kliff and Azeen Ghorayshi
Source link
